Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$447K Buy
566
+5
+0.9% +$3.59K 0.15% 121
2025
Q1
$374K Buy
561
+51
+10% +$37.1K 0.13% 128
2024
Q4
$353K Buy
+510
New +$366K 0.11% 139
2022
Q3
Sell
-1,760
Closed -$838K 235
2022
Q2
$838K Buy
1,760
+60
+4% +$33.5K 0.34% 109
2022
Q1
$1.14M Sell
1,700
-578
-25% -$387K 0.41% 90
2021
Q4
$1.81M Buy
2,278
+499
+28% +$396K 0.66% 45
2021
Q3
$1.32M Buy
1,779
+618
+53% +$486K 0.53% 68
2021
Q2
$789K Buy
1,161
+392
+51% +$259K 0.34% 101
2021
Q1
$490K Buy
+769
New +$427K 0.26% 134

Other funds holding ASML

Wambolt & Associates's ASML Position: Q2 2025 in Review

Wambolt & Associates increased its ASML (ASML) stake by 0.89% in Q2 2025, buying an estimated $3.59K and bringing the position to 566 shares worth $447K. The position accounts for 0.15% of the portfolio, ranked #121.

Wambolt & Associates first reported a position in ASML in Q1 2021 and has held it in 9 quarters since. The position peaked at $1.81M in Q4 2021. 1,714 funds tracked by Wall St. Rank hold ASML as of Q2 2025.

  • Wambolt & Associates held 566 shares of ASML worth $447K as of Q2 2025.
  • Wambolt & Associates bought 5 ASML shares in Q2 2025, an estimated $3.59K.
  • ASML made up 0.15% of Wambolt & Associates's portfolio in Q2 2025, its #121 holding.
  • Wambolt & Associates first reported a position in ASML in Q1 2021 and has held it in 9 quarters since.
  • Wambolt & Associates's ASML position peaked at $1.81M in Q4 2021.
  • 1,714 funds tracked by Wall St. Rank held ASML as of Q2 2025.

Based on Wambolt & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.